Yes, its in the last 10Q, note #9 on page 16, under related
Yes, its in the last 10Q, note #9 on page 16, under related party transactions. It does appear to be convoluted, but the question is whether there is anything not kosher? Or anything directly in conflict with the clinical trials proposed or underway?
Ehrlich knows he needs an independent BoD to uplist. The sooner he garners independent oversight, the more confidence he will instill in shareholders and institutions going forward.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sivers Semiconductors Announces Partnership with DigiKey In an exciting development for the tech industry, Sivers Semiconductors AB (STO:SIVE), known for its expertise in photonics and wireless technologies, has formed a strategic partnership with DigiKey. This collaboration is designed to enhance the accessibility of Sivers' cutting-edge millimeter-wave products and...
Continue Reading
Transformative Partnership in Personal Injury Law LawPro.ai, an innovative AI-powered case intelligence platform designed to enhance case preparation, has joined forces with SmartAdvocate, a renowned case management system favored by legal professionals countrywide. This collaboration aims to revolutionize the workflow in personal injury law, enabling firms to prepare...
Continue Reading
Transforming the UK Tyre Industry Tyres.co.uk is gearing up to shake up the UK's extensive and lucrative tyre market. With an advanced technological platform and a prime domain name, this startup aims to streamline the tyre buying and fitting process for motorists across the nation. As the launch date approaches, anticipation grows for how this service will enhance the...
Continue Reading
Exploring Body Image in Today's Society In a world where social media and advertising continually influence our perceptions of beauty, Adam & Eve has remained a beacon of body positivity and self-acceptance. This renowned company conducted a revealing survey among over 1,000 adults, asking an intriguing question: "What’s the one thing you would change about your body if...
Continue Reading
Eyes on the Earnings: What to Expect from ESTA Okay, let's cut to the chase. February 24, 2026—a date that's gonna hit the calendar hard for investors in Establishment Labs Hldgs (NASDAQ:ESTA). They're gearing up to toss out their quarterly earnings, and honestly, folks have their fingers crossed. Analysts point to an expected earnings per share (EPS) of $-0.22. Not...
Continue Reading
